Physician profile
Kimberly Blind
NPI 1275958910
$496.66
in general payments reported to CMS, 2019-2025
14 companies · $78.64 in 2025
The $78.64 reported for 2025 was less than what a typical Perioperative provider received nationally (typical 2025 total: $130).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.40 · 2022: $60.53 · 2023: $56.63 · 2024: $204 · 2025: $78.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $114.61 | 2021-2025 | Lithovue, Angiojet Ultra 5000a, Enroute Transcarotid Neuroprotection System |
| Intuitive Surgical, INC. | $66.37 | 2024 | |
| Stryker Corporation | $56.02 | 2023-2024 | Mako |
| Abbvie INC. | $42.55 | 2021-2022 | |
| Seapearl East, INC | $35.78 | 2022-2024 | |
| Endomagnetics Ltd | $30.05 | 2024 | Magseed, Magtrace |
| Integra Lifesciences Corporation | $26.80 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medtronic, INC. | $23.28 | 2021 | |
| Hologic Sales and Service, LLC | $23.08 | 2025 | Coolseal Generator |
| Shockwave Medical, INC | $18.19 | 2022 | |
| Solventum Corporation | $16.08 | 2025 | Prevena, V.A.C.Ulta |
| Vertex Pharmaceuticals Incorporated | $15.15 | 2025 | |
| Ethicon US, LLC | $14.78 | 2021 | |
| Kci USA, INC. | $13.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Blind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.